speb/financial-data huggingface dataset:
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 832515335.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5399000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 3800000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 8761000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6446000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Other Income Expense: 478000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 100942000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -5000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 212000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1052000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -2365000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Payable: 11555000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 23103000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 59905000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Payables: 59431000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 86651000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 7531000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 18350000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 464000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -4912000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -90610000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5223000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Raw Materials: 25825000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Receivables: 120841000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 39911000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5051000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -239000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Research And Development: 6202000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 337683000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Sale Of Intangibles: 239000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 90929000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 110000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 26436000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 834613760.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: -354000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 100000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 358489000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 245249000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 92130000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 4082000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -5657000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 542005000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 358489000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 58539000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 362082000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 70184000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 179923000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 262488000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28996000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 17513000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 7628000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 415000000.00
DRREDDY.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 415000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 2098425.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1937000000.00
DRREDDY.NS cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -547000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Work In Process: 17580000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 128590000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 32476000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 87268000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 40796000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 103206000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 11504000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1824000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 2036000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 2036000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 2402000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2954000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 832622161.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 14.53
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9906000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7320000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 13646000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 835000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18657000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82589000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 1517000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 17140000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7777000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -10292000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10908000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2158000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1955000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Payable: -1668000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1668000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -2345000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -8126000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 8393000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Common Stock: 835000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 372366000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 30000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 40462000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 26430000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Assets: 297549000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2038000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Debt: 54086000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 56124000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1780000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1780000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 158310000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Current Provisions: 6599000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 3532000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 3532000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Depreciation: 3177000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5213000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5213000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 833195592.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 14.52
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 12098000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — EBIT: 16373000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — EBITDA: 21586000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 23000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -23000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 358000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — End Cash Position: 18657000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1648000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 7777000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 34927000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 3588000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 179000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1316000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Goodwill: 12410000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 114727000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 105030000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 46806000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 259000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 271000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 944000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 944000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Interest Income: 796000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 796000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -936000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 359000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Inventory: 79009000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 426452000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -10292000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 4602000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 9950000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 30000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 50286000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 11608000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11608000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -288000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 5348000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 105000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 3390000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 202000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 30000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Net Debt: 35429000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -310000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income: 12098000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 12098000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 11896000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 12098000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 12098000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 11897000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 11896000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -474000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -148000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -3483000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 8683000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -288000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -148000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Net PPE: 115544000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -6694000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 8971000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 257639000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 2786000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 21247000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 16482000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 1707000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 21247000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14775000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 884000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 20362000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 11154173600.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 10908000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -512000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Operating Income: 14330000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 87268000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 832568190.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 5249000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3800000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 9255000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 8169000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Other Income Expense: 1247000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 102317000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 148000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 212000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 638000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -591000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Payable: 11731000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 21063000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 63932000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Payables: 58122000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 84552000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 6174000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 15429000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -29000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -616000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -38050000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -6704000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Raw Materials: 26289000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Receivables: 124269000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 40462000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5213000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -288000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Research And Development: 6149000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 349783000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Sale Of Intangibles: 142000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 34567000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 10000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 26918000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Share Issued: 834630355.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -92000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 20000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 372366000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 257639000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 280173600.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 3533000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -3067000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Assets: 562899000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 372366000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Debt: 67732000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 375756000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 72938000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 187143000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 265350000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 28833000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 14238000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 5595000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 1224000000.00
DRREDDY.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1224000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2062165.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 1904000000.00
DRREDDY.NS cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -570000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Work In Process: 17793000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-12-31) — Working Capital: 139239000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — +Operating Expense: 127141000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 42206000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — +Total Revenue: 335933000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 75162000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 22362000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 22362000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 101219000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 101219000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -103866000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -103866000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 11537000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 11537000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1847000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1847000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 7985000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 2118000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Amortization Of Intangibles: 7985000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 2118000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 11036000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 4522000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 7958000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 7958000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 832440587.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 833584906.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Basic EPS: 51.48
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.65
DRREDDY.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 14593000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 18657000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 44840000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 44840000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -38425000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -10823000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 14407000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 14407000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 835000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 835000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 15368000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 15368000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 87814000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 87814000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -6659000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 1118000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1118000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 14250000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 14250000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 8290000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 7039000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -65513000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -26486000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 56755000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 15645000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Account Payable: 2790000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -8601000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Inventory: 1743000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Other Working Capital: 897000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 6570000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2790000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Payable: -4388000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 2790000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4388000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -6722000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3312000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -11636000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 7237000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Changes In Account Receivables: -6722000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -468000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3802000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Common Stock: 835000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 835000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 377063000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 377063000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 397000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 79000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: 0.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 15409000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 15409000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 158669000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 32127000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 27920000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 27920000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Assets: 301975000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 301975000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 2204000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2204000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Debt: 62934000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 62934000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 65138000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 65138000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 1581000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1581000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 1581000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1581000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 167566000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 167566000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 7550000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 7550000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Deferred Income Tax: 12351000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -214000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 12351000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -214000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Depreciation: 12620000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Depreciation: 3458000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 20605000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5576000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 20588000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 5571000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 20605000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5576000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 20588000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 5571000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 833331689.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 833584906.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Diluted EPS: 51.42
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.65
DRREDDY.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 42850000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2209000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
DRREDDY.NS income_statement (annual, 2026-03-31) — EBIT: 58555000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — EBIT: 3054000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — EBITDA: 79160000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — EBITDA: 8630000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Earnings From Equity Interest: 134000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 46000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Earnings Losses From Equity Investments: -134000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -46000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 1243000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 513000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — End Cash Position: 15368000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — End Cash Position: 15368000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2737000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2737000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 8290000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 7039000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 33100000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 33100000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 18330000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 4822000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Gain On Sale Of Ppe: 2547000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 4144000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3979000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 59909000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 14468000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Goodwill: 12893000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 12893000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 117952000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 117952000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 103066000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 103066000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 219796000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 219796000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Gross Profit: 177264000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 43035000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 155000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 155000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 3519000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 2575000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Interest Expense: 3738000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1057000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 3738000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1057000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Interest Income: 3726000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 3726000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -4441000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -1240000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 1521000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 403000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Inventory: 76531000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 76531000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 439997000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 439997000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -65513000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -26486000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 10695000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 10695000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Investments And Advances: 16368000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 16368000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 397000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 79000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 4346000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 4346000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Line Of Credit: 59135000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 59135000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 12203000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 12203000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 12203000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 12203000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12203000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 12203000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1264000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -411000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 5673000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 5673000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 109000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 109000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 155200000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 155200000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 3394000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 3394000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Minority Interests: 384000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -4000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -3203000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -3152000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 397000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 79000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Net Debt: 47566000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 47566000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -529000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 290000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income: 42850000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income: 2209000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 42850000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2209000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 42466000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2213000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 42850000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2209000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 42850000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2209000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 42466000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2205000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 42466000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2213000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -13698000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -5265000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Interest Income: -12000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1057000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -27116000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -14091000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 18993000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 8200000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -1264000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -411000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -12000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1057000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Net PPE: 115930000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 115930000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -23017000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4381000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 20257000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 8611000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 259111000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 259111000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Accounts Receivable: 3459000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 3459000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 22436000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 22436000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 18004000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 18004000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 2436000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 2436000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 22436000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 22436000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 15568000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 15568000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 904000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 904000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 74588000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 11205000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Normalized Income: 39329560000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 3754000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 56755000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 15645000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Operating Gains Losses: -3210000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1856000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Operating Income: 50123000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Operating Income: 829000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Operating Revenue: 335933000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 75162000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 832691395.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 832691395.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 6023000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6023000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 3799000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3799000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 16137000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 16137000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3979000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 10543000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 10543000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Other Income Expense: 4706000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Other Income Expense: 2225000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 105059000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 105059000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Investments: 10695000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Investments: 10695000000.00
DRREDDY.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 12000000.00
DRREDDY.NS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 167000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 322000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 322000000.00
DRREDDY.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1007000000.00
DRREDDY.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1007000000.00
DRREDDY.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 13584000000.00
DRREDDY.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 4754000000.00